S-3 S-3 EX-FILING FEES 0001253689 CRESCENT BIOPHARMA, INC. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0001253689 2026-06-16 2026-06-16 0001253689 1 2026-06-16 2026-06-16 0001253689 2 2026-06-16 2026-06-16 0001253689 3 2026-06-16 2026-06-16 0001253689 4 2026-06-16 2026-06-16 0001253689 5 2026-06-16 2026-06-16 0001253689 6 2026-06-16 2026-06-16 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

CRESCENT BIOPHARMA, INC.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Equity Ordinary Shares, $0.001 par value per share 457(o)
Equity Preferred Shares, $0.001 par value per share 457(o)
Debt Debt Securities 457(o)
Other Warrants 457(o)
Other Units 457(o)
Fees to be Paid 1 Unallocated (Universal) Shelf 457(o) $ 500,000,000.00 0.0001381 $ 69,050.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 500,000,000.00

$ 69,050.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 69,050.00

Offering Note

1

The securities covered by this registration statement to be sold by the Registrant may be sold separately or in any combination with other securities registered under this registration statement from time to time in one or more offerings. There are being registered hereunder such indeterminate number or amount, as the case may be, of (i) ordinary shares, (ii) preferred shares, (iii) debt securities, (iv) warrants and/or (v) units consisting of some or all of these securities in any combination, as may be sold from time to time by the Registrant. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. There are also being registered hereunder an indeterminable number of ordinary shares and debt securities as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The proposed maximum offering price per security and the proposed aggregate offering price per class of security will be determined from time to time by the Registrant of the securities registered hereunder and is not specified as to each class of security. No separate consideration will be received for ordinary shares that are issued upon conversion or exchange of any preferred shares, debt securities, warrants or units registered hereunder. The registration fee has been calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended. The aggregate maximum offering price is estimated solely for the purpose of calculating the registration fee. The aggregate maximum offering price of all securities issued by the Registrant pursuant to this registration statement will not exceed $500,000,000.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date